Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

534 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase III study of infliximab and corticosteroids for the initial treatment of acute graft-versus-host disease.
Couriel DR, Saliba R, de Lima M, Giralt S, Andersson B, Khouri I, Hosing C, Ippoliti C, Shpall EJ, Champlin R, Alousi A. Couriel DR, et al. Among authors: shpall ej. Biol Blood Marrow Transplant. 2009 Dec;15(12):1555-62. doi: 10.1016/j.bbmt.2009.08.003. Epub 2009 Sep 25. Biol Blood Marrow Transplant. 2009. PMID: 19896079 Free PMC article. Clinical Trial.
Clofarabine ± fludarabine with once daily i.v. busulfan as pretransplant conditioning therapy for advanced myeloid leukemia and MDS.
Andersson BS, Valdez BC, de Lima M, Wang X, Thall PF, Worth LL, Popat U, Madden T, Hosing C, Alousi A, Rondon G, Kebriaei P, Shpall EJ, Jones RB, Champlin RE. Andersson BS, et al. Among authors: shpall ej. Biol Blood Marrow Transplant. 2011 Jun;17(6):893-900. doi: 10.1016/j.bbmt.2010.09.022. Epub 2010 Oct 11. Biol Blood Marrow Transplant. 2011. PMID: 20946966 Free PMC article. Clinical Trial.
Prophylaxis of graft-versus-host disease in unrelated donor transplantation with pentostatin, tacrolimus, and mini-methotrexate: a phase I/II controlled, adaptively randomized study.
Parmar S, Andersson BS, Couriel D, Munsell MF, Fernandez-Vina M, Jones RB, Shpall EJ, Popat U, Anderlini P, Giralt S, Alousi A, Cano P, Bosque D, Hosing C, Silva Lde P, Westmoreland M, Wathen JK, Berry D, Champlin RE, de Lima MJ. Parmar S, et al. Among authors: shpall ej. J Clin Oncol. 2011 Jan 20;29(3):294-302. doi: 10.1200/JCO.2010.30.6357. Epub 2010 Dec 13. J Clin Oncol. 2011. PMID: 21149654 Free PMC article. Clinical Trial.
Mesenchymal stem cells in ex vivo cord blood expansion.
Robinson SN, Simmons PJ, Yang H, Alousi AM, Marcos de Lima J, Shpall EJ. Robinson SN, et al. Among authors: shpall ej. Best Pract Res Clin Haematol. 2011 Mar;24(1):83-92. doi: 10.1016/j.beha.2010.11.001. Epub 2011 Feb 23. Best Pract Res Clin Haematol. 2011. PMID: 21396596 Free PMC article. Review.
Gemcitabine, fludarabine and melphalan as a reduced-intensity conditioning regimen for allogeneic stem cell transplant in relapsed and refractory Hodgkin lymphoma: preliminary results.
Anderlini P, Saliba RM, Ledesma C, Chancoco C, Alousi AM, Shpall EJ, Popat UR, Hosing CM, Khouri IF, Nieto Y, Ciurea S, Younes A, Fanale MA, Acholonu S, Valverde R, Champlin RE. Anderlini P, et al. Among authors: shpall ej. Leuk Lymphoma. 2012 Mar;53(3):499-502. doi: 10.3109/10428194.2011.615427. Epub 2011 Oct 24. Leuk Lymphoma. 2012. PMID: 21859247 Free PMC article. Clinical Trial. No abstract available.
Steroid-Refractory Acute GVHD: Predictors and Outcomes.
Westin JR, Saliba RM, De Lima M, Alousi A, Hosing C, Qazilbash MH, Khouri IF, Shpall EJ, Anderlini P, Rondon G, Andersson BS, Champlin R, Couriel DR. Westin JR, et al. Among authors: shpall ej. Adv Hematol. 2011;2011:601953. doi: 10.1155/2011/601953. Epub 2011 Nov 3. Adv Hematol. 2011. PMID: 22110505 Free PMC article.
534 results